Literature DB >> 12634382

Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.

Zijiang Zhao1, Takaji Wakita, Kotaro Yasui.   

Abstract

We established a simple and effective method for DNA immunization against Japanese encephalitis virus (JEV) infection with plasmids encoding the viral PrM and E proteins and colloidal gold. Inoculation of plasmids mixed with colloidal gold induced the production of specific anti-JEV antibodies and a protective response against JEV challenge in BALB/c mice. When we compared the efficacy of different inoculation routes, the intravenous and intradermal inoculation routes were found to elicit stronger and more sustained neutralizing immune responses than intramuscular or intraperitoneal injection. After being inoculated twice, mice were found to resist challenge with 100,000 times the 50% lethal dose (LD(50)) of JEV (Beijing-1 strain) even when immunized with a relatively small dose of 0.5 micro g of plasmid DNA. Protective passive immunity was also observed in SCID mice following transfer of splenocytes or serum from plasmid DNA- and colloidal gold-immunized BALB/c mice. The SCID mice resisted challenge with 100 times the LD(50) of JEV. Analysis of histological sections detected expression of proteins encoded by plasmid DNA in the tissues of intravenously, intradermally, and intramuscularly inoculated mice 3 days after inoculation. DNA immunization with colloidal gold elicited encoded protein expression in splenocytes and might enhance immune responses in intravenously inoculated mice. This approach could be exploited to develop a novel DNA vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634382      PMCID: PMC150624          DOI: 10.1128/jvi.77.7.4248-4260.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice.

Authors:  D Chen; R L Endres; C A Erickson; K F Weis; M W McGregor; Y Kawaoka; L G Payne
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

2.  Functions of signal and signal-anchor sequences are determined by the balance between the hydrophobic segment and the N-terminal charge.

Authors:  M Sakaguchi; R Tomiyoshi; T Kuroiwa; K Mihara; T Omura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Targeting dendritic cells to enhance DNA vaccine potency.

Authors:  Z You; X Huang; J Hester; H C Toh; S Y Chen
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

4.  Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.

Authors:  A C Stubbs; K S Martin; C Coeshott; S V Skaates; D R Kuritzkes; D Bellgrau; A Franzusoff; R C Duke; C C Wilson
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

5.  Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

Authors:  S Pincus; P W Mason; E Konishi; B A Fonseca; R E Shope; C M Rice; E Paoletti
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

6.  Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.

Authors:  H W Chen; C H Pan; M Y Liau; R Jou; C J Tsai; H J Wu; Y L Lin; M H Tao
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children.

Authors:  C C Ku; C C King; C Y Lin; H C Hsu; L Y Chen; Y Y Yueh; G J Chang
Journal:  J Med Virol       Date:  1994-10       Impact factor: 2.327

9.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product.

Authors:  T Sato; C Takamura; A Yasuda; M Miyamoto; K Kamogawa; K Yasui
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

View more
  9 in total

1.  Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection.

Authors:  Tao Chen; Shuo Zhu; Ning Wei; Zikai Zhao; Junjun Niu; Youhui Si; Shengbo Cao; Jing Ye
Journal:  Viruses       Date:  2022-05-24       Impact factor: 5.818

Review 3.  Recent progress in West Nile virus diagnosis and vaccination.

Authors:  Marina De Filette; Sebastian Ulbert; Mike Diamond; Niek N Sanders
Journal:  Vet Res       Date:  2012-03-01       Impact factor: 3.683

4.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

Review 5.  Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.

Authors:  Sónia Alexandra Correia Carabineiro
Journal:  Molecules       Date:  2017-05-22       Impact factor: 4.411

6.  Japanese encephalitis-a pathological and clinical perspective.

Authors:  Debapriya Ghosh; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

Review 7.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

8.  The prM-independent packaging of pseudotyped Japanese encephalitis virus.

Authors:  Hee Jung Lee; Kyung-Il Min; Jungeun Lee; Sin-Hyung Kang; Wonkyung Jeon; Jae Hwan Nam; Young Ran Ju; Young Bong Kim
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

9.  An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

Authors:  Dhiraj Acharya; Fengwei Bai
Journal:  Methods Mol Biol       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.